Doihara; Hitoshi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Doihara; Hitoshi.The latest application filed is for "conjugate comprising ligand and ceacam5 antibody fab fragment".
- Doihara; Hitoshi - Chuo-Ku Tokyo
- DOIHARA; Hitoshi - Tokyo JP
| Patent | Date |
|---|---|
| Conjugate Comprising Ligand And Ceacam5 Antibody Fab Fragment App 20220096653 - Akaiwa; Michinori ; et al. | 2022-03-31 |
| Novel Anti-human Muc1 Antibody Fab Fragment App 20200261603 - MORINAKA; Akifumi ; et al. | 2020-08-20 |
| Novel Anti-human Muc1 Antibody Fab Fragment App 20200171174 - MORINAKA; Akifumi ; et al. | 2020-06-04 |
| Novel Anti-human Ceacam5 Antibody Fab Fragment App 20200123270 - Doihara; Hitoshi ; et al. | 2020-04-23 |
| Anti-human MUC1 antibody Fab fragment Grant 10,517,966 - Morinaka , et al. Dec | 2019-12-31 |
| Anti-human MUC1 antibody fab fragment Grant 10,507,251 - Morinaka , et al. Dec | 2019-12-17 |
| Novel Anti-human Muc1 Antibody Fab Fragment App 20190307906 - MORINAKA; Akifumi ; et al. | 2019-10-10 |
| Novel Anti-human Muc1 Antibody Fab Fragment App 20190269804 - Morinaka; Akifumi ; et al. | 2019-09-05 |
| Screening method for prokinetic agent Grant 8,034,574 - Nozawa , et al. October 11, 2 | 2011-10-11 |
| Indolinone Compound App 20110009379 - Kaku; Hidetaka ; et al. | 2011-01-13 |
| Treatment for irritable bowel syndrome Grant 7,842,702 - Takezawa , et al. November 30, 2 | 2010-11-30 |
| Screening Method For Prokinetic Agent App 20100129345 - Nozawa; Katsura ; et al. | 2010-05-27 |
| Treatment For Irritable Bowel Syndrome App 20080188512 - Takezawa; Ryuichi ; et al. | 2008-08-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 